Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Using ultrasound transmission velocity to analyse the mechanical properties of teeth after in vitro, in situ, and in vivo irradiation
2000
Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties
1993
Cancer to bone: a fatal attraction
2011 Standout
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Zygomycosis Due to Mucor circinelloides in a Neutropenic Patient Receiving Chemotherapy for Acute Myelogenous Leukemia
1994
Macrophages in immunoregulation and therapeutics
2023 Standout
Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis
2003
Vitamin D Deficiency
2007 Standout
Accurate assessment of precision errors: How to measure the reproducibility of bone densitometry techniques
1995 Standout
Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives
2011
Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia
2003
Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions
2010
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Cathepsin K inhibitors as treatment of bone metastasis
2008
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis
2008
Intracellular Staphylococcus aureus in bone and joint infections: A mechanism of disease recurrence, inflammation, and bone and cartilage destruction
2020
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Calcimimetics: a remedy for all problems of excess parathyroid hormone activity in chronic kidney disease?
2005
Extracellular matrix structure
2015 Standout
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma
1992
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4
2004
The epidemiology of quantitative ultrasound: A review of the relationships with bone mass, osteoporosis and fracture risk
1997
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
2015
Bone mineral density and bone histomorphometry in children on long-term dialysis
2007
Nocardiosis at the Turn of the Century
2009 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Potential new drug targets for osteoporosis
2008
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D
2006
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
2006
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
1999
Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis
2014
MYC oncogenes and human neoplastic disease
1999
Chronic Kidney Disease
2016 Standout
Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation
2000
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
2007
Update on the use of cinacalcet in the management of primary hyperparathyroidism.
2012
Zygomycetes in Human Disease
2000 Standout
Infections in solid-organ transplant recipients
1997
Site-matched calcaneal measurements of broad-band ultrasound attenuation and single X-ray absorptiometry: Do they measure different skeletal properties?
1992
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
Role of Vitamin D Deficiency in Chronic Kidney Disease
2007
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Physiology and pathophysiology of the calcium-sensing receptor in the kidney
2009
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis
1997
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Vitamin D and Immune Function
2013 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Mineralized bone loss at different sites in dialysis patients
1998
Vitamin D compounds for people with chronic kidney disease requiring dialysis
2009
Renal Control of Calcium, Phosphate, and Magnesium Homeostasis
2014 Standout
Vascular Calcification
2006 Standout
Bone metabolism and disease in chronic kidney disease
2003
Quantitative Ultrasound Techniques for the Assessment of Osteoporosis: Expert Agreement on Current Status
1997
Oral Sequelae of Head and Neck Radiotherapy
2003 Standout
Safety and Efficacy of Risedronate in Patients With Age-Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical Trials
2005
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of N.A.T. Hamdy being referenced
Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)
2014
Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy
1991
Mutations in the Coding Region of c-myc Occur Independently of Mutations in the Regulatory Regions and are Predominantly Associated with myc/lg Translocation
1995
Fatal Cardiac Zygomycosis in a Renal Transplant Patient Treated with Desferrioxamine
1989
Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure
1995
The spectrum of renal bone disease
1995
Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to ade novoinactivating mutation of the calcium‐sensing receptor
2006
Denosumab: RANKL inhibition in the management of bone loss
2008
Broadband ultrasound attenuation in the os calcis: relationship to bone mineral at other skeletal sites
1990